{"entity":{"type":"insider","cik":"0001760303","url":"/insider/0001760303","json_url":"/insider/0001760303.json","name":"Somaiya Mayur Ian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":5,"first":"2020-11-19","last":"2026-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Somaiya Mayur Ian","source":"filing","n_filings":5,"first_seen":"2020-11-19","last_seen":"2026-01-22"}],"transactions":[{"id":6133533,"accession":"0001193125-26-019686","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-019686","line_url":"/filing/0001193125-26-019686","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39784.0,"shares_display":"39,784","price_per_share":33.58679619947718,"price_display":"33.59","price_state":"stated","total_value":1336217.1,"total_display":"1,336,217.10","total_whole":"1,336,217","shares_owned_after":58382.0,"shares_owned_after_display":"58,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-22","scope":"insider","n_lines":2},{"id":6133525,"accession":"0001193125-26-019686","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-019686","line_url":"/filing/0001193125-26-019686","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60216.0,"shares_display":"60,216","price_per_share":31.958298126743724,"price_display":"31.96","price_state":"stated","total_value":1924400.88,"total_display":"1,924,400.88","total_whole":"1,924,401","shares_owned_after":77986.0,"shares_owned_after_display":"77,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider","n_lines":3},{"id":5943185,"accession":"0001193125-26-006658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006658","line_url":"/filing/0001193125-26-006658#line-1","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5118.0,"shares_display":"5,118","price_per_share":33.25,"price_display":"33.25","price_state":"stated","total_value":170173.5,"total_display":"170,173.50","total_whole":"170,174","shares_owned_after":32882.0,"shares_owned_after_display":"32,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4233796,"accession":"0000950170-25-010594","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-25-010594","line_url":"/filing/0000950170-25-010594#line-6","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11495.0,"shares_display":"11,495","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":41405.0,"shares_owned_after_display":"41,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-29","scope":"insider"},{"id":4233793,"accession":"0000950170-25-010594","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-010594","line_url":"/filing/0000950170-25-010594#line-5","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3405.0,"shares_display":"3,405","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":38000.0,"shares_owned_after_display":"38,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-29","scope":"insider"},{"id":4233782,"accession":"0000950170-25-010594","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-010594","line_url":"/filing/0000950170-25-010594#line-3","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33679.0,"shares_display":"33,679","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":51304.0,"shares_owned_after_display":"51,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":4233778,"accession":"0000950170-25-010594","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-010594","line_url":"/filing/0000950170-25-010594#line-2","is_derivative":false,"issuer_cik":"0001760303","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001760303","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13304.0,"shares_display":"13,304","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":38000.0,"shares_owned_after_display":"38,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":2249121,"accession":"0000899243-20-034089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034089","line_url":"/filing/0000899243-20-034089#line-2","is_derivative":false,"issuer_cik":"0001750019","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001750019","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":70000.0,"total_display":"70,000.00","total_whole":"70,000","shares_owned_after":1473.0,"shares_owned_after_display":"1,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2120204,"accession":"0001209191-20-059443","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-059443","line_url":"/filing/0001209191-20-059443","is_derivative":false,"issuer_cik":"0001750019","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001750019","owner_cik":"0001760303","owner_name":"Somaiya Mayur Ian","owner_display_name":"Somaiya Mayur Ian","owner_url":"/insider/0001760303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3666.0,"shares_display":"3,666","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":109980.0,"total_display":"109,980.00","total_whole":"109,980","shares_owned_after":3139.0,"shares_owned_after_display":"3,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001936258","name":"NewAmsterdam Pharma Co N.V.","url":"/issuer/0001936258","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2025-01-29","last_seen":"2026-01-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001750019","name":"TCR2 THERAPEUTICS INC.","url":"/issuer/0001750019","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2020-11-19","last_seen":"2020-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001760303","retrieved_at":"2026-08-23T03:26:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}